FMOC-D-Lys(BOC)-OH

Product Details

CAS No:92122-45-7

MF:C26H32N2O6

Appearance:white or off-white crystalline powder

Specification:98.5%

UN number:-

Package:1/5/10/25kgs/drum

Supply Capacity:Tons

Product application:Fmoc-D-Lys(Boc)-OH, 92122-45-7, Fmoc-D-Lysine(Boc)-OH, N-alpha-Fmoc-N-epsilon-Boc-D-lysine, D-Lysine derivative, Fmoc protected amino acids, Boc protected D-lysine, solid phase peptide synthesis (SPPS), chiral building blocks, pharmaceutical intermediates, peptide drug discovery, custom peptide synthesis, biochemical reagents, amino acid derivatives, Fmoc-D-Lys(Boc)-OH manufacturer, high purity D-lysine derivatives, polypeptide synthesis raw materials.

Synonyms:FMOC-D-Lys(BOC)-OH; N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-epsilon-tert-butyl-oxycarbonyl-D-lysine; Nα-FMoc-Nε-Boc-D-lysine;(R)-2-((((9H-Fluoren-9-yl)Methoxy)carbonyl)aMino)-6-((tert-butoxycarbonyl)aMino)hexanoic acid;Fmoc-D-Lys(Boc)-OH 98%;N(e)-Boc-N(α)-Fmoc-D-lysine;Nε-(tert-Butoxycarbonyl)-Nα-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine;Nα-Fmoc-Nε-Boc-D-lysine≥ 99% (HPLC);(9H-Fluoren-9-yl)MethOxy]Carbonyl D-Lys(Boc)-OH;N2-(((9H-Fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-D-lysine; (2R)-6-(((tert-butoxy)carbonyl)amino)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoic acid,"(2R)-6-{[(tert-butoxy)carbonyl]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)hexanoic acid; (2R)-6-(((tert-butoxy)carbonyl)amino)-2-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)hexanoic acid; 804-633-0; Fmoc-D-Lys(Boc)-OH; 92122-45-7; MFCD00065660; C26H32N2O6; (R)-6-[(tert-Butoxycarbonyl)amino]-2-[[[(9H-fluoren-9-yl)methoxy]carbonyl]amino]hexanoic acid; (2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)-6-[(2-methylpropan-2-yl)oxycarbonylamino]hexanoic acid; N2-(((9H-fluoren-9-yl)methoxy)carbonyl)-N6-(tert-butoxycarbonyl)-D-lysine; N(EPSILON)-(TERT-BUTOXYCARBONYL)-N(ALPHA)-9-FLUORENYLMETHOXYCARBONYL-D-LYSINE; N6-[(1,1-DIMETHYLETHOXY)CARBONYL]-N2-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-D-LYSINE; N-alpha-Fmoc-N-epsilon-Boc-D-lysine; Nepsilon-(tert-Butoxycarbonyl)-Nalpha-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-lysine; (R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-6-((tert-butoxycarbonyl)amino)hexanoic acid; FmocDLys(Boc)OH; N6-?[(1,?1-?Dimethylethoxy)?carbonyl]?-?N2-?[(9H-?fluoren-?9-?ylmethoxy)?carbonyl]?-D-?lysine; Na-Fmoc-Ne-Boc-D-lysine; orb2940351; S3CY44CF48; SCHEMBL2524769; SCHEMBL29370147; SCHEMBL30886226; Fmoc-D-Lys(Boc)-OH, 98%; DTXSID90544408; Nepsilon-Boc-Nalpha-Fmoc-D-lysine; N-alpha-Fmoc-Nepsilon-Boc-D-lysine; N alpha-Fmoc-N epsilon-Boc-D-lysine; AKOS016842972; N(e)-Boc-N( alpha )-Fmoc-D-lysine; CS-W007655; FF47343; HY-W007655; (2R)-6-(tert-butoxycarbonylamino)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hexanoic acid; AS-14296; SY023950; B3071; EN300-136573; F11080; M03424; Z1675256531; (R)-6-tert-Butoxycarbonylamino-2-(9H-fluoren-9-ylmethoxycarbonylamino)-hexanoic acid; D-LYSINE, N6-[(1,1-DIMETHYLETHOXY)CARBONYL]-N2-[(9H-FLUOREN-9-YLMETHOXY)CARBONYL]-; N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N-EPSILON-T-BUTYL-OXYCARBONYL-D-LYSINE; N~6~-(tert-Butoxycarbonyl)-N~2~-{[(9H-fluoren-9-yl)methoxy]carbonyl}-D-lysine",468.500,C26H32N2O6,